The galactosemia treatment market is poised for robust expansion, projected to surpass USD 570 million in 2025, continuing its growth to nearly USD 900 million by 2032. This growth is primarily underpinned by enhanced early diagnosis through newborn screening and the massive investment in Gene Therapy Development. The market is transitioning from a reliance on dietary management towar... https://www.databridgemarketresearch.com/reports/global-galactosemia-treatment-market